The role of blood and brain 5-hydroxymethylcytosine in linking vascular risk factors to ADRD in older White and Black persons

血液和脑 5-羟甲基胞嘧啶在老年白人和黑人血管危险因素与 ADRD 之间的联系中的作用

基本信息

  • 批准号:
    10315659
  • 负责人:
  • 金额:
    $ 327.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-15 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ ABSTRACT Alzheimer’s Disease (AD) is a chronic and disabling condition, the 6th leading cause of death in the US, and a major cause of personal, societal, and global burden. Yet, our understanding of pathobiologic mechanisms underlying dementia and cognitive impairment in aging remains incomplete, and this gap in knowledge hinders scientific advancement and improved clinical care and prevention. Vascular conditions such as diabetes mellitus (DM) are common, especially among minority racial groups, and recognized as increasing dementia risk. Because these factors are modifiable by treatment and lifestyle approaches, research linking vascular factors to Alzheimer’s Disease/ Alzheimer’s Disease-Related Dementias (AD/ADRD) is more important than ever. Emerging data suggests that the epigenome likely plays a role in this link, and novel methods to study the epigenome are now available. 5-hydroxymethylcytosine (5hmC) is an epigenetic modification of cytosine for which we can now measure genome-wide changes in circulating cell-free DNA (cfDNA) in blood and genomic DNA (gDNA) in tissues. Our group has developed a highly sensitive and selective analytic approach to capture and sequence 5hmC-containing DNA fragments in order to map genome-wide distributions, and have successfully used this approach to develop 5hmC scores which distinguish between patients with and without different conditions, including in recent studies of AD and DM. In response to the pressing need to better understand the pathobiologic underpinnings of AD/ADRD, we propose a collaborative project with the overall goal of elucidating epigenetic mechanisms linking vascular risk factors to AD/ADRD clinical and pathological phenotypes, in older Whites and Blacks. The proposed study will leverage available resources from two community-based cohort studies, including research participants from which to collect blood specimens, as well as extensive longitudinal clinical data and postmortem neuropathologic data, and biospecimens (e.g., frozen brain tissue samples). Among White and Black persons, we will collect new genome-wide 5hmC data to generate serum-specific (Aims 1 and 4) and brain-specific 5hmC scores (Aims 2 and 4), using discovery and validation experiments in different sets of persons, that distinguishes between persons with and without dementia. We will then link the blood and brain 5hmC data to AD/ADRD clinical and pathologic phenotypes, including incident dementia and cognitive decline (Aims 1 and 4), cerebrovascular and AD pathology (Aim 2). We will further examine if relations are differential by vascular risk factors (DM, blood pressure [BP], and body mass index [BMI]) and by other factors (e.g., sex; Aims1-4), and if generalizable to Black persons (Aim 4). Because vascular risk factors are common and modifiable, this study which will elucidate 5hmC mechanisms in AD/ADRD and vascular diseases among White and Black older persons, will fill a major gap in scientific knowledge about dementia and provide important data to inform future research and to ultimately improve clinical dementia care and prevention.
项目概要/摘要 阿尔茨海默病 (AD) 是一种慢性致残性疾病,是美国第六大死因,也是 个人、社会和全球负担的主要原因。然而,我们对病理生物学机制的理解 衰老过程中潜在的痴呆和认知障碍仍然不完整,这种知识差距阻碍了 科学进步和改善临床护理和预防。血管疾病,例如糖尿病 糖尿病(DM)很常见,尤其是在少数族裔群体中,并被认为是痴呆症的增加 风险。由于这些因素可以通过治疗和生活方式来改变,因此研究将血管 导致阿尔茨海默病/阿尔茨海默病相关痴呆 (AD/ADRD) 的因素比 曾经。新出现的数据表明表观基因组可能在这一联系中发挥着作用,以及新的研究方法 表观基因组现已可用。 5-羟甲基胞嘧啶 (5hmC) 是胞嘧啶的表观遗传修饰 为此,我们现在可以测量血液中循环游离 DNA (cfDNA) 的全基因组变化, 组织中的基因组 DNA (gDNA)。我们的团队开发了一种高度灵敏和选择性的分析方法 捕获并测序包含 5hmC 的 DNA 片段,以绘制全基因组分布图,以及 已成功地使用这种方法开发了 5hmC 评分,用于区分患有和 没有不同的条件,包括最近的 AD 和 DM 研究。为了响应迫切需要 为了更好地了解 AD/ADRD 的病理生物学基础,我们提出了一个与 阐明将血管危险因素与 AD/ADRD 临床和治疗联系起来的表观遗传机制的总体目标 老年白人和黑人的病理表型。拟议的研究将利用现有资源 来自两项基于社区的队列研究,包括收集血液的研究参与者 标本,以及广泛的纵向临床数据和死后神经病理学数据,以及 生物样本(例如冷冻脑组织样本)。在白人和黑人中,我们将收集新的 全基因组 5hmC 数据,用于生成血清特异性(目标 1 和 4)和大脑特异性 5hmC 评分(目标 2 4),在不同的人群中进行发现和验证实验,区分 患有或未患有痴呆症的人。然后,我们将血液和大脑 5hmC 数据与 AD/ADRD 临床和 病理表型,包括痴呆和认知能力下降(目标 1 和 4)、脑血管和 AD 病理学(目标 2)。我们将进一步检查关系是否因血管危险因素(DM、血液 压力 [BP] 和体重指数 [BMI])以及其他因素(例如性别;目标 1-4),并且如果可以概括为 黑人(目标 4)。由于血管危险因素很常见且可以改变,因此本研究将 阐明白人和黑人老年人 AD/ADRD 和血管疾病中的 5hmC 机制,将 填补有关痴呆症的科学知识的重大空白,并为未来的研究提供重要数据 并最终改善临床痴呆症护理和预防。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zoe Arvanitakis其他文献

Zoe Arvanitakis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zoe Arvanitakis', 18)}}的其他基金

Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4
大脑 cPLA2 作为 AD/ADRD 神经炎症的机制,有或没有 APOE4
  • 批准号:
    10464564
  • 财政年份:
    2022
  • 资助金额:
    $ 327.52万
  • 项目类别:
Vascular Cognitive and Motor Decline: Impact of aPL
血管认知和运动衰退:aPL 的影响
  • 批准号:
    8336938
  • 财政年份:
    2011
  • 资助金额:
    $ 327.52万
  • 项目类别:
Vascular Cognitive and Motor Decline: Impact of aPL
血管认知和运动衰退:aPL 的影响
  • 批准号:
    8881036
  • 财政年份:
    2011
  • 资助金额:
    $ 327.52万
  • 项目类别:
Vascular Cognitive and Motor Decline: Impact of aPL
血管认知和运动衰退:aPL 的影响
  • 批准号:
    8728095
  • 财政年份:
    2011
  • 资助金额:
    $ 327.52万
  • 项目类别:
Vascular Cognitive and Motor Decline: Impact of aPL
血管认知和运动衰退:aPL 的影响
  • 批准号:
    8526334
  • 财政年份:
    2011
  • 资助金额:
    $ 327.52万
  • 项目类别:
Vascular Cognitive and Motor Decline: Impact of aPL
血管认知和运动衰退:aPL 的影响
  • 批准号:
    8234526
  • 财政年份:
    2011
  • 资助金额:
    $ 327.52万
  • 项目类别:
Oxidative Stress, Aging and Alzheimer's Disease
氧化应激、衰老和阿尔茨海默病
  • 批准号:
    7556333
  • 财政年份:
    2005
  • 资助金额:
    $ 327.52万
  • 项目类别:
Oxidative Stress, Aging and Alzheimer's Disease
氧化应激、衰老和阿尔茨海默病
  • 批准号:
    7007680
  • 财政年份:
    2005
  • 资助金额:
    $ 327.52万
  • 项目类别:
Oxidative Stress, Aging and Alzheimer's Disease
氧化应激、衰老和阿尔茨海默病
  • 批准号:
    7367080
  • 财政年份:
    2005
  • 资助金额:
    $ 327.52万
  • 项目类别:
Oxidative Stress, Aging and Alzheimer's Disease
氧化应激、衰老和阿尔茨海默病
  • 批准号:
    6868496
  • 财政年份:
    2005
  • 资助金额:
    $ 327.52万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 327.52万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 327.52万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 327.52万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 327.52万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 327.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 327.52万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 327.52万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 327.52万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 327.52万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 327.52万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了